Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Patients Aged 70 Years or Older.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
10 2019
Historique:
received: 21 01 2019
revised: 01 04 2019
accepted: 15 04 2019
pubmed: 12 6 2019
medline: 17 1 2020
entrez: 12 6 2019
Statut: ppublish

Résumé

There is uncertainty whether venoarterial extracorporeal membrane oxygenation (VA-ECMO) should be used in older patients with cardiopulmonary failure after cardiac surgery. This was a retrospective multicenter study of 781 patients who required postcardiotomy VA-ECMO for cardiopulmonary failure after adult cardiac surgery from 2010 to 2018 at 19 cardiac surgery centers. A parallel systematic review with meta-analysis of the literature was performed. The hospital mortality in the overall Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation (PC-ECMO) series was 64.4%. A total of 255 patients were 70 years old or older (32.7%), and their hospital mortality was significantly higher than in younger patients (76.1% vs 58.7%; adjusted odds ratio, 2.199; 95% confidence interval [CI], 1.536 to 3.149). Arterial lactate level greater than 6 mmol/L before starting VA-ECMO was the only predictor of hospital mortality among patients 70 years old or older in univariate analysis (82.6% vs 70.4%; P = .029). Meta-analysis of current and previous studies showed that early mortality after postcardiotomy VA-ECMO was significantly higher in patients aged 70 years or older compared with younger patients (odds ratio, 2.09; 95% CI, 1.59 to 2.75; 5 studies including 1547 patients; I Advanced age should not be considered a contraindication for postcardiotomy VA-ECMO. However, in view of the high risk of early mortality, meaningful scrutiny is needed before using VA-ECMO after cardiac surgery in older patients.

Sections du résumé

BACKGROUND
There is uncertainty whether venoarterial extracorporeal membrane oxygenation (VA-ECMO) should be used in older patients with cardiopulmonary failure after cardiac surgery.
METHODS
This was a retrospective multicenter study of 781 patients who required postcardiotomy VA-ECMO for cardiopulmonary failure after adult cardiac surgery from 2010 to 2018 at 19 cardiac surgery centers. A parallel systematic review with meta-analysis of the literature was performed.
RESULTS
The hospital mortality in the overall Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation (PC-ECMO) series was 64.4%. A total of 255 patients were 70 years old or older (32.7%), and their hospital mortality was significantly higher than in younger patients (76.1% vs 58.7%; adjusted odds ratio, 2.199; 95% confidence interval [CI], 1.536 to 3.149). Arterial lactate level greater than 6 mmol/L before starting VA-ECMO was the only predictor of hospital mortality among patients 70 years old or older in univariate analysis (82.6% vs 70.4%; P = .029). Meta-analysis of current and previous studies showed that early mortality after postcardiotomy VA-ECMO was significantly higher in patients aged 70 years or older compared with younger patients (odds ratio, 2.09; 95% CI, 1.59 to 2.75; 5 studies including 1547 patients; I
CONCLUSIONS
Advanced age should not be considered a contraindication for postcardiotomy VA-ECMO. However, in view of the high risk of early mortality, meaningful scrutiny is needed before using VA-ECMO after cardiac surgery in older patients.

Identifiants

pubmed: 31185202
pii: S0003-4975(19)30809-4
doi: 10.1016/j.athoracsur.2019.04.063
pii:
doi:

Types de publication

Journal Article Meta-Analysis Multicenter Study Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1257-1264

Informations de copyright

Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Fausto Biancari (F)

Heart Center, Turku University Hospital and Department of Surgery, University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland. Electronic address: faustobiancari@yahoo.it.

Diyar Saeed (D)

Department of Cardiovascular Surgery, University Hospital of Dusseldorf, Dusseldorf, Germany.

Antonio Fiore (A)

Department of Cardiothoracic Surgery, Henri Mondor University Hospital, AP-HP, Paris-Est University, Créteil, France.

Magnus Dalén (M)

Department of Molecular Medicine and Surgery, and Department of Cardiac Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Vito G Ruggieri (VG)

Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France.

Kristján Jónsson (K)

Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Giuseppe Gatti (G)

Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy.

Svante Zipfel (S)

Hamburg University Heart Center, Hamburg, Germany.

Angelo M Dell'Aquila (AM)

Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany.

Sidney Chocron (S)

Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France.

Karl Bounader (K)

Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France.

Gilles Amr (G)

Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France.

Nicla Settembre (N)

Department of Vascular Surgery, Nancy University Hospital, University of Lorraine, Nancy, France.

Kristiina Pälve (K)

Heart Center, Turku University Hospital and Department of Surgery, University of Turku, Turku, Finland.

Antonio Loforte (A)

Department of Cardiothoracic, Transplantation, and Vascular Surgery, S. Orsola Hospital, University of Bologna, Bologna, Italy.

Marco Gabrielli (M)

Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy.

Ugolino Livi (U)

Cardiothoracic Department, University Hospital of Udine, Udine, Italy.

Andrea Lechiancole (A)

Cardiothoracic Department, University Hospital of Udine, Udine, Italy.

Marek Pol (M)

Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Ivan Netuka (I)

Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Cristiano Spadaccio (C)

Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Matteo Pettinari (M)

Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.

Dieter De Keyzer (D)

Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.

Daniel Reichart (D)

Hamburg University Heart Center, Hamburg, Germany.

Sigurdur Ragnarsson (S)

Department of Cardiothoracic Surgery, University of Lund, Lund, Sweden.

Khalid Alkhamees (K)

Prince Sultan Cardiac Center, Al Hassa, Saudi Arabia.

Artur Lichtenberg (A)

Department of Cardiovascular Surgery, University Hospital of Dusseldorf, Dusseldorf, Germany.

Thomas Fux (T)

Department of Molecular Medicine and Surgery, and Department of Cardiac Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Zein El Dean (Z)

Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.

Mariafrancesca Fiorentino (M)

Department of Cardiothoracic, Transplantation, and Vascular Surgery, S. Orsola Hospital, University of Bologna, Bologna, Italy.

Giovanni Mariscalco (G)

Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.

Anders Jeppsson (A)

Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Henryk Welp (H)

Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany.

Andrea Perrotti (A)

Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH